MedTrace Logo

STA-21 Topical Efficacy on Psoriasis

NCT01047943 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 8

Last updated 2010-01-13

No results posted yet for this study

Summary

The clinical assessment of patients with plaque-type psoriasis is performed by open, intrapatient comparison of 0.2% STA-21 with vehicle(Vaseline) alone within a 2 week period.

Conditions

Interventions

DRUG

Topical application of STA-21 ointment for treatment of psoriasis

Sponsors & Collaborators

  • Kochi University

    lead OTHER

Principal Investigators

  • Shigetoshi Sano, M.D., Ph.D. · Department of Dermatology, Kochi Medical School, Kochi University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
SINGLE_GROUP

Eligibility

Min Age
20 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-06-30
Primary Completion
2008-04-30
Completion
2008-04-30

Countries

  • Japan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01047943 on ClinicalTrials.gov